Andrew Morris

Andrew Morris is currently the Chief Executive Officer at ROSE Diagnostics Inc. and serves as a Co-founder and Advisor at FORGE Hydrocarbons, where they are instrumental in developing renewable fuels. With extensive experience in senior leadership roles focused on operations, financial strategy, and corporate development in the technology and healthcare sectors, Andrew has held positions such as Vice President of M&A at Ernst & Young Corporate Finance and President at Rare Management Advisors. They are also a mentor at the Creative Destruction Lab's Biomedical Engineering Stream and have previously served as CEO of SQI Diagnostics and Managing Partner at Attwill Medical Solutions. Andrew holds an MBA in Finance from the University of Toronto - Rotman School of Management and a Master's in Exercise Physiology from the University of Toronto.